The Nature and Treatment of Anxiety Disorders |
From inside the book
Results 1-3 of 42
Page 128
... dose users will experience withdrawal . Rickels et al . ( 1986 ) found evidence for physical dependence in 82 percent of 119 chronic low - dose benzodiazepine users . In a recent study , Busto et al . ( 1986 ) provided convincing ...
... dose users will experience withdrawal . Rickels et al . ( 1986 ) found evidence for physical dependence in 82 percent of 119 chronic low - dose benzodiazepine users . In a recent study , Busto et al . ( 1986 ) provided convincing ...
Page 286
... dose , and dose range of the available ben- zodiazepines can be seen in Table 11.1 TABLE 11.1 Benzodiazepines Generic Representative Initial Usual Brand Oral Dose Dose ( mg ) Range ( mg / day ) Longer Half - Life Chlordiazepoxide ...
... dose , and dose range of the available ben- zodiazepines can be seen in Table 11.1 TABLE 11.1 Benzodiazepines Generic Representative Initial Usual Brand Oral Dose Dose ( mg ) Range ( mg / day ) Longer Half - Life Chlordiazepoxide ...
Page 287
... dose . The rate of absorption through the gastrointestinal mucosa is most rapid for the highly lipophilic com- pounds diazepam and clorazepate , which reach peak plasma con- centrations within an hour . Temazepam and oxazepam are ...
... dose . The rate of absorption through the gastrointestinal mucosa is most rapid for the highly lipophilic com- pounds diazepam and clorazepate , which reach peak plasma con- centrations within an hour . Temazepam and oxazepam are ...
Contents
Theories of Anxiety | 15 |
Anxiety Syndromes and Disorders | 43 |
An Overview of Symptom | 69 |
Copyright | |
13 other sections not shown
Other editions - View all
Common terms and phrases
activity acute agoraphobia agoraphobic agoraphobic patients alcohol alprazolam antidepressants anxiety disorders anxiolytic anxious patients arousal assessment associated avoidance behavior therapy Behaviour Research benzodiazepines buspirone BZDs cause changes chapter clinical cognitive therapy common coping criteria depression developed diagnosis diazepam discussed dose drive drugs DSM-III-R evaluation experience experienced exposure therapy factors feeling frequently function heart rate hyperventilation iety imipramine important increased intensity intervention involved Journal of Psychiatry Joyce lactate locus coeruleus lorazepam MAOI measures medication ment months muscle occur onset panic attacks panic disorder panic disorder patients patients with panic percent person phenelzine physiologic practice present problems procedure propanolol Psychiatry psychological psychotherapy reduce relaxation reported Research and Therapy response self-efficacy self-statements sensations session side effects simple phobias social phobia social phobics somatic stimuli stress studies syndrome tasks TCAs theory therapeutic therapist thoughts tients tion treat treatment vivo exposure walk weeks withdrawal worry